BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30556899)

  • 1. Integration of metabolomic and transcriptomic data reveals metabolic pathway alteration in breast cancer and impact of related signature on survival.
    Luo X; Yu H; Song Y; Sun T
    J Cell Physiol; 2019 Aug; 234(8):13021-13031. PubMed ID: 30556899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative Pathway Analysis of Metabolic Signature in Bladder Cancer: A Linkage to The Cancer Genome Atlas Project and Prediction of Survival.
    von Rundstedt FC; Rajapakshe K; Ma J; Arnold JM; Gohlke J; Putluri V; Krishnapuram R; Piyarathna DB; Lotan Y; Gödde D; Roth S; Störkel S; Levitt JM; Michailidis G; Sreekumar A; Lerner SP; Coarfa C; Putluri N
    J Urol; 2016 Jun; 195(6):1911-9. PubMed ID: 26802582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of potential biomarkers and metabolic pathways based on integration of metabolomic and transcriptomic data in the development of breast cancer.
    Yang Y; Zhu Y; Li X; Zhang X; Yu B
    Arch Gynecol Obstet; 2021 Jun; 303(6):1599-1606. PubMed ID: 33791842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-based metabolomics reveals metabolic signatures and major metabolic pathways of gastric cancer with help of transcriptomic data from TCGA.
    Wang Y; Chen W; Li K; Wu G; Zhang W; Ma P; Feng S
    Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34549263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of Overall Survival Among Female Patients With Breast Cancer Using a Prognostic Signature Based on 8 DNA Repair-Related Genes.
    Zhang D; Yang S; Li Y; Yao J; Ruan J; Zheng Y; Deng Y; Li N; Wei B; Wu Y; Zhai Z; Lyu J; Dai Z
    JAMA Netw Open; 2020 Oct; 3(10):e2014622. PubMed ID: 33017027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
    Fang E; Zhang X
    Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel secretome-to-transcriptome integrated or secreto-transcriptomic approach to reveal liquid biopsy biomarkers for predicting individualized prognosis of breast cancer patients.
    Ankney JA; Xie L; Wrobel JA; Wang L; Chen X
    BMC Med Genomics; 2019 May; 12(1):78. PubMed ID: 31146747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Value of miR-101-3p and Biological Analysis of its Prospective Targets in Breast Cancer: A Study Based on The Cancer Genome Atlas (TCGA) and Bioinformatics.
    Li CY; Xiong DD; Huang CQ; He RQ; Liang HW; Pan DH; Wang HL; Wang YW; Zhu HW; Chen G
    Med Sci Monit; 2017 Apr; 23():1857-1871. PubMed ID: 28416776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of the potential biomarkers for early diagnosis of endometrial cancer via integrating metabolomics and transcriptomics.
    Fu Y; Wang C; Wu Z; Zhang X; Liu Y; Wang X; Liu F; Chen Y; Zhang Y; Zhao H; Wang Q
    Comput Biol Med; 2024 May; 173():108327. PubMed ID: 38552279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of the lncRNA‑associated competing endogenous RNA network in breast cancer.
    Wang JJ; Huang YQ; Song W; Li YF; Wang H; Wang WJ; Huang M
    Oncol Rep; 2019 Dec; 42(6):2572-2582. PubMed ID: 31638237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative Analysis of Metabolomic and Transcriptomic Data Reveals Metabolic Alterations in Glioma Patients.
    Shi Y; Ding D; Liu L; Li Z; Zuo L; Zhou L; Du Q; Jing Z; Zhang X; Sun Z
    J Proteome Res; 2021 May; 20(5):2206-2215. PubMed ID: 33764076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CMap analysis identifies Atractyloside as a potential drug candidate for type 2 diabetes based on integration of metabolomics and transcriptomics.
    Li H; Shi X; Jiang H; Kang J; Yu M; Li Q; Yu K; Chen Z; Pan H; Chen W
    J Cell Mol Med; 2020 Jul; 24(13):7417-7426. PubMed ID: 32469143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the key pathways and genes involved in HER2-positive breast cancer with brain metastasis.
    Lu X; Gao C; Liu C; Zhuang J; Su P; Li H; Wang X; Sun C
    Pathol Res Pract; 2019 Aug; 215(8):152475. PubMed ID: 31178227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Clinicopathological Significance and Correlative Signaling Pathways of an Autophagy-Related Gene, Ambra1, in Breast Cancer: a Study of 25 Microarray RNA-Seq Datasets and in-House Gene Silencing.
    He RQ; Xiong DD; Ma J; Hu XH; Chen G; Sun WL
    Cell Physiol Biochem; 2018; 51(3):1027-1040. PubMed ID: 30476925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of ENTPD8 and cytidine in pancreatic cancer by metabolomic and transcriptomic conjoint analysis.
    An Y; Cai H; Yang Y; Zhang Y; Liu S; Wu X; Duan Y; Sun D; Chen X
    Cancer Sci; 2018 Sep; 109(9):2811-2821. PubMed ID: 29987902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Metabolic Profiling Identified a Distinct Metabolic Signature in Bladder Cancer Smokers: A Key Metabolic Enzyme Associated with Patient Survival.
    Amara CS; Ambati CR; Vantaku V; Badrajee Piyarathna DW; Donepudi SR; Ravi SS; Arnold JM; Putluri V; Chatta G; Guru KA; Badr H; Terris MK; Bollag RJ; Sreekumar A; Apolo AB; Putluri N
    Cancer Epidemiol Biomarkers Prev; 2019 Apr; 28(4):770-781. PubMed ID: 30642841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic fingerprinting in breast cancer stages through
    Suman S; Sharma RK; Kumar V; Sinha N; Shukla Y
    J Pharm Biomed Anal; 2018 Oct; 160():38-45. PubMed ID: 30059813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Hub Genes Using Co-Expression Network Analysis in Breast Cancer as a Tool to Predict Different Stages.
    Fu Y; Zhou QZ; Zhang XL; Wang ZZ; Wang P
    Med Sci Monit; 2019 Nov; 25():8873-8890. PubMed ID: 31758680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated bioinformatics analysis reveals key candidate genes and pathways in breast cancer.
    Wang Y; Zhang Y; Huang Q; Li C
    Mol Med Rep; 2018 Jun; 17(6):8091-8100. PubMed ID: 29693125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human plasma metabolomics for identifying differential metabolites and predicting molecular subtypes of breast cancer.
    Fan Y; Zhou X; Xia TS; Chen Z; Li J; Liu Q; Alolga RN; Chen Y; Lai MD; Li P; Zhu W; Qi LW
    Oncotarget; 2016 Mar; 7(9):9925-38. PubMed ID: 26848530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.